Arrowstreet Capital’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.43M | Buy |
123,604
+107,023
| +645% | +$1.24M | ﹤0.01% | 1529 |
|
|
2025
Q1 | $145K | Buy |
+16,581
| New | +$145K | ﹤0.01% | 1754 |
|
|
2022
Q3 | – | Sell |
-5,846
| Closed | -$265K | – | 1465 |
|
|
2022
Q2 | $265K | Buy |
+5,846
| New | +$265K | ﹤0.01% | 1139 |
|
|
2021
Q4 | – | Sell |
-27,100
| Closed | -$3.95M | – | 1733 |
|
|
2021
Q3 | $3.95M | Buy |
27,100
+4,500
| +20% | +$655K | ﹤0.01% | 986 |
|
|
2021
Q2 | $4.43M | Buy |
+22,600
| New | +$4.43M | 0.01% | 1108 |
|
|
2021
Q1 | – | Sell |
-2,600
| Closed | -$368K | – | 2544 |
|
|
2020
Q4 | $368K | Sell |
2,600
-41,166
| -94% | -$5.83M | ﹤0.01% | 2078 |
|
|
2020
Q3 | $5.46M | Sell |
43,766
-32,900
| -43% | -$4.1M | 0.01% | 1109 |
|
|
2020
Q2 | $6.85M | Buy |
+76,666
| New | +$6.85M | 0.01% | 933 |
|